Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages

  Bhasin, Neeraj ^a,b   Ariëns, Robert A S ^a   West, Robert M ^a   Parry, Duncan J ^a,b   Grant, Peter J ^a   Scott, D Julian A ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR SURGERY;

EID: 57949113332     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.07.010     Document Type: Article

References (31)

1. Ariens R.A.S., de Lange M., Snieder H., Boothby M., Spector T.D., and Grant P.J. Activation markers of coagulation and fibrinolysis in twins: heritability of the pre-thrombotic state. Lancet 359 (2002) 667-671
2. Dunn E.J., Ariëns R.A.S., de Lange M., Sneider H., Turney J.H., Spector T.D., et al. Genetics of fibrin clot structure: a twin study. Blood 103 (2004) 1735-1740
3. Mills J.D., Ariens R.A., Mansfield M.W., and Grant P.J. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 106 (2002) 1938-1942
4. Hippe M., Vestbo J., Hein H.O., Borch-Johnsen K., Jensen G., and Sorensen T.I. Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. J Epidemiol Community Health 53 (1999) 269-276
5. Souto J.C., Almasy L., Borrell M., Gari M., Martinez E., Mateo J., et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101 (2000) 1546-1551
6. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and De Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
7. Belch J.J., Topol E.J., Agnelli G., Bertrand M., Califf R.M., Clement D.L., et al. Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163 (2003) 884-892
8. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Eng J Med 326 (1992) 381-386
9. Valentine R.J., Verstraete R., Clagett G.P., and Cohen J.C. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med 160 (2000) 1343-1348
10. Parry D.J., Grant P.J., and Scott D.J.A. Atherothrombotic risk factor clustering in healthy male relatives of male patients with intermittent claudication. J Vasc Surg 40 (2004) 891-898
11. Leng G.C., and Fowkes F.G. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 45 (1999) 1101-1109
12. Rose G., McCartney P., and Reid D.D. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prevent Social Med 31 (1977) 41-48
13. Undas A., Celinska-Löwenhoff M., Löwenhoff T., and Szczeklik A. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 4 (2006) 1029-1036
14. Nair C.H., Azhar A., and Dhall D.P. Studies of fibrin network structure in human plasma. Part II: clinical application-diabetes and antidiabetic drugs. Thromb Res 64 (1991) 477-485
15. Jorneskog G., Hansson L.O., Wallen N.H., Yngen M., and Blomback M. Increased plasma fibrin gel porosity in patients with type I diabetes during continuous subcutaneous insulin infusion. J Thromb Haemost 1 (2003) 1195-1201
16. Williams S., Fatah K., Hjemdahl P., and Blomback M. Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. European Heart Journal 19 (1998) 1666-1672
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-441
18. Ariens R.A., Philippou H., Nagaswami C., Weisel J.W., Lane D.A., and Grant P.J. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96 (2000) 988-995
19. Weisel J.W., and Nagaswami C. Computer modeling of fibrin polymerisation kinetics closely correlates with electron microscopy and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 63 (1992) 111-128
20. Ariens R.A.S., Kohler H.P., Mansfield M.W., and Grant P.J. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to gender, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 19 (1999) 2012-2016
21. Fatah K., Silveira A., Tornvall P., Karpe F., Blomback M., and Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 76 (1996) 535-540
22. Dunn E.J., Ariëns R.A.S., and Grant P.J. The influence of type 2 diabetes on fibrin structure and function. Diabetologia 48 (2005) 1198-1206
23. Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalescot G., et al. Influence of fibrin network conformation and fibrin fibre diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20 (2000) 1354-1361
24. Muszbek L., Yee V.C., and Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 94 (1999) 271-305
25. Ariens R.A., Lai T.S., Weisel J.W., Greenberg C.S., and Grant P.J. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100 (2002) 743-754
26. Scott E.M., Ariëns R.A.S., and Grant P.J. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 24 (2004) 1558-1566
27. de Lange M., Snieder H., Ariens R.A., Spector T.D., and Grant P.J. The genetics of haemostasis: a twin study. Lancet 357 (2001) 101-105
28. Foy C.A., and Grant P.J. Genes and the development of vascular disease. Postgrad Med J 73 (1997) 271-278
29. Lusis A.J. Genetic factors in cardiovascular disease. 10 questions. Trends Cardiovasc Med 13 (2003) 309-316
30. Iliadou A., and Snieder H. Genetic epidemiological approaches in the study of risk factors for cardiovascular disease. Eur J Epidemiol 19 (2004) 209-217
31. Vogt M.T., Cauley J.A., Kuller L.H., and Hulley S.B. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 137 (1993) 559-568